Asia Pacific Immunotech Venture Limited - Net Worth and Insider Trading
Asia Pacific Immunotech Venture Limited Net Worth
The estimated net worth of Asia Pacific Immunotech Venture Limited is at least $679 Million dollars as of 2024-09-14. Asia Pacific Immunotech Venture Limited is the of Mabpharm Ltd and owns about 2,227,000,000 shares of Mabpharm Ltd (HKSE:02181) stock worth over $679 Million. Details can be seen in Asia Pacific Immunotech Venture Limited's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Asia Pacific Immunotech Venture Limited has not made any transactions after 2019-05-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Asia Pacific Immunotech Venture Limited
Asia Pacific Immunotech Venture Limited Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Asia Pacific Immunotech Venture Limited owns 1 companies in total, including Mabpharm Ltd (HKSE:02181) .
Insider Ownership Summary of Asia Pacific Immunotech Venture Limited
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:02181 | Mabpharm Ltd | 2019-05-31 |
Asia Pacific Immunotech Venture Limited Latest Holdings Summary
Asia Pacific Immunotech Venture Limited currently owns a total of 1 stock. Asia Pacific Immunotech Venture Limited owns 2,227,000,000 shares of Mabpharm Ltd (HKSE:02181) as of May 31, 2019, with a value of $679 Million.
Latest Holdings of Asia Pacific Immunotech Venture Limited
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:02181 | Mabpharm Ltd | 2019-05-31 | 2,227,000,000 | 0.31 | 679,235,000 |
Holding Weightings of Asia Pacific Immunotech Venture Limited
Asia Pacific Immunotech Venture Limited Form 4 Trading Tracker
According to the SEC Form 4 filings, Asia Pacific Immunotech Venture Limited has made a total of 0 transactions in Mabpharm Ltd (HKSE:02181) over the past 5 years. The most-recent trade in Mabpharm Ltd is the sale of 0 shares on May 31, 2019, which brought Asia Pacific Immunotech Venture Limited around $0.
Insider Trading History of Asia Pacific Immunotech Venture Limited
- 1
Asia Pacific Immunotech Venture Limited Trading Performance
Asia Pacific Immunotech Venture Limited Ownership Network
Asia Pacific Immunotech Venture Limited Owned Company Details
What does Mabpharm Ltd do?
Who are the key executives at Mabpharm Ltd?
Asia Pacific Immunotech Venture Limited is the of Mabpharm Ltd. Other key executives at Mabpharm Ltd include 2307 Founder of a discretionary trust who can infl Guo Jianjun , Asia Mabtech Limited , and Guo Family (ptc) Limited .
Mabpharm Ltd (HKSE:02181) Insider Trades Summary
Over the past 18 months, Asia Pacific Immunotech Venture Limited made no insider transaction in Mabpharm Ltd (HKSE:02181). Other recent insider transactions involving Mabpharm Ltd (HKSE:02181) include a net sale of 0 shares made by Guo Jianjun ,
In summary, during the past 3 months, insiders sold 0 shares of Mabpharm Ltd (HKSE:02181) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Mabpharm Ltd (HKSE:02181) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Mabpharm Ltd (HKSE:02181)'s detailed insider trading history can be found in Insider Trading Tracker table.
Mabpharm Ltd Insider Transactions
Asia Pacific Immunotech Venture Limited Mailing Address
Above is the net worth, insider trading, and ownership report for Asia Pacific Immunotech Venture Limited. Currently GuruFocus does not have mailing address information for Asia Pacific Immunotech Venture Limited.
Discussions on Asia Pacific Immunotech Venture Limited
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
